glp-1 news october 16 2025 What's next for innovation: A primer on the race reshaping pharma and chronic disease care Who Gets the Shot? GLP-1

Promotes healthy blood vessel formation and function, supporting cardiovascular health and optimal tissue perfusion throughout the body

Used for tissue repair, tendon healing, and gut health

Several different photoproducts were formed in UV/Cl 2 photolysis processes, including carbamazepine epoxide, chlorinated products, or four-membered ring derivatives (Fig

Recent Industry Developments FDA Approval of Oral Wegovy and Orforglipron (Regulatory): On December 22, 2025, the FDA approved the first oral GLP-1 specifically for chronic weight management (the Wegovy pill), which launched in January 2026

460 In recent years, several molecular pathways with simultaneously large/microvascular protective effects have been identified (PPAR-, CXCR4, etc.), but most of them are still in animal experiments or phase I clinical stage

Charles W